Infant ibuprofen recall expanded

Tris Pharma has expanded its November voluntary recall of infant ibuprofen oral suspension drops over concerns that the concentration of ibuprofen is too high.

The Food and Drug Administration (FDA) warns that the ibuprofen concentration could be as much as ten percent above the specified limit.

Affected brands include CVS Health and Equate, which is sold at Walmart.

To check if your medicine is included in the recall, visit

Share this article: